Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA [Phase 3]

View source ↗

Summary

A Phase 3 study is evaluating the efficacy and safety of ENIA11 in combination with methotrexate versus methotrexate alone in patients with rheumatoid arthritis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENIA11
  • METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Mycenax Biotech Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN